The largest database of trusted experimental protocols

Sitagliptin

Manufactured by Yuanye Bio-Technology
Sourced in China

Sitagliptin is a pharmaceutical compound used as a laboratory reagent. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which plays a role in glucose metabolism. The core function of Sitagliptin is to inhibit the DPP-4 enzyme, thereby affecting the regulation of blood glucose levels. Detailed information regarding its intended use or applications is not available.

Automatically generated - may contain errors

2 protocols using sitagliptin

1

Pharmacological Modulation of GLP-1 and GLP-2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Afatinib was acquired from Zhengzhou Acme Chem Co., Ltd. (Zhengzhou, China). Sitagliptin was procured from Shanghai yuanye Bio-Technology Co., Ltd. (Shanghai, China). GLP-23-33 was obtained from Nanjing Peptide Biotech Ltd. (Nanjing, China). Gly-Pro-7-AMC was sourced from Sigma-Aldrich (St. Louis, MO, USA). The Invitrogen™ TRIzol reagent was obtained from Thermo Fisher Scientific (Waltham, MA, USA). The Prime Script RT Reagent Kit and SYBR Premix Ex Taq Kit were purchased from Takara Biomedical Technology (Dalian, China). Total GLP-1 ELISA kit and total GLP-2 ELISA kit were acquired from CUSABIO Biotech CO., Ltd. (Wuhan, China), while the active GLP-1 (GLP-17-36) ELISA kit were from ALPCO (Salem, USA).
+ Open protocol
+ Expand
2

Sitagliptin-Target Protein Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the affinity and kinetics between sitagliptin and the novel target, we performed this experiment using Biacore T200 (GE Healthcare) instrument based on SPR, and used GraphPad Prism 8.0 software to visualize the data results (18 (link), 19 (link)).
Firstly, the amino acid sequence of the target protein was searched by Uniprot database, and the sequence was imported into Expasy (https://web.expasy.org/) website to calculate the isoelectric point of the protein (20 (link)). Then, the preconcentration experiment was carried out to determine the optimal coupling conditions. The target protein was coupled to CM5 chip (GE Healthcare) using the Immobilization module in Biacore T200 Control Software, and the reference channel was set to deduct the background. The chip was activated by EDC/NHS (GE Healthcare), and the uncoupling site was blocked by ethanolamine (GE Healthcare).
sitagliptin (HPLC ≥ 98%, Shanghai yuanye Bio-Technology Co., Ltd) was dissolved in DMSO (VWR) solution and diluted with PBS-P+ (GE Healthcare) solution to the desired compound concentration (1×PBS-P+, 5% DMSO). The affinity and kinetics of sitagliptin with the novel target protein were tested by LMW kinetics module in Biacore T200 Control Software, and extra wash after injection with 50% DMSO was added.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!